Prescient Healthcare Group, a biopharmaceutical product strategy and decision support consultancy, has named Dr Debasish Talukdar as its new vice president, global head of advisory.
His new role will see him take responsibility for the future trajectory for the group’s advisory practice.
Talukdar said: “I’m very excited to have joined Prescient and see huge opportunity to grow VantageRX, our advisory services business.
“We have an incredible team that offers a differentiated level of service to our clients through in-depth technical, therapeutic and market expertise.”
He joins the group from Bain & Company, where he was a leader in the healthcare practice gaining expertise in advising biopharma clients on value creation through corporate, business unit, disease area and product-focused strategies.
Jamie Denison-Pender, chief executive officer of Prescient, said: “His [Talukdar] tier 1 consultancy experience coupled with his medical background makes him a fantastic fit for us.
“Debasish has a real passion for problem solving and is an expert at understanding the nuances associated with a client need and then framing an optimal solution.”